Safety and efficacy assessment of Product on ski
- Registration Number
- CTRI/2024/03/063536
- Lead Sponsor
- DPKA Universal Consumer Ventures Private. Limited.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1) Indian / Asian female subjects
2) Healthy subjects
3) Having dull skin & having wheatish to dark skin.
4) 15 normal skin volunteers,35 dry skin volunteers
5) 10 sensitive skin. (declared through lactic acid sting test)
1.Being pregnant or breastfeeding or having stopped to breastfeed in the past three months
2.Having refused to give her assent by signing the consent form
3.Taking part in another study liable to interfere with this study
4.Having a chronic dermatosis liable to modify the cutaneous reactivity on the tested area
5.Being insulin-dependent diabetic or non insulin-dependent diabetic with a recent therapy (less
than 6 months)
6.Having a progressive asthma (either under treatment or last fit in the last 2 years)
7.Being epileptic
8.Having non stabilized thyroid problems (requirement of a stabilized treatment for at least 6 months)
9.Having cutaneous hypersensitivity
10.Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic
products or food products or to latex
11.Following a chronic medicinal treatment comprising any of the following products: aspirin-based products, anti-inflammatories, anti-histamines, corticotherapy, taken by general or local routes
(the only medication permitted is paracetamol)
12.Having undergone a surgery requiring a general anaesthetic of more than one hour in the past 6
months.
13.Having changed her cosmetic habits in the 14 days preceding the start of the study on the studied anatomic unit
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement in skin brightening, skin hydration, skin smoothness, skin pH balance and skin water barrier functionTimepoint: Baseline, 30 minutes, 2 hour, 4 hour, 7 days, 14 days
- Secondary Outcome Measures
Name Time Method ilTimepoint: NA